Short CommunicationIndian Journal of Pharmacy PracticeVol. 7 | Issue 3 | pp. 75–77Open access
Atorvastatin Induced Vasculitis
- 1*,
- 2,
- 3,
- 3,
- 3,
- 4
- 1 Scientific Assistant.
- 2 Principal Scientific Officer.
- 3 Technical Associtae.
- 4 Secretary-cum-Scientific Director, National Coordination Centre-Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Sector-23, Raj Nagar Ghaziabad, Uttar Pradesh -201002, India.
Published in Indian Journal of Pharmacy Practice
Correspondence: Prasad T
Scientific Assistant.
Email: prasad.thota187@gmail.com
- Received:
- Apr 25, 2014
- Accepted:
- Sep 12, 2014
- DOI:
- 10.5530/ijopp.7.3.13
How to cite
T, P., V, K., S, S., D, V., S, R., & S, G. N. Atorvastatin Induced Vasculitis. Indian Journal of Pharmacy Practice, 7(3), 75–77. https://doi.org/10.5530/ijopp.7.3.13
Abstract
Adverse drug reactions are regarded as an important public health problem as they may be potentially life- threatening. The World Health Organization defines Adverse drug reaction (Adverse Drug Reaction) as a response to a drug which is noxious, unintended, which occurs at doses normally used in human for prophylaxis or diagnosis of a disease or for modification of physiological function. We report two adverse drug reaction case reports. Case 1: A forty six years old Indian female adult developed Vasculitis over both legs and back after four months. Patient was prescribed Tablet Atorvastatin 20 mg, Tablet Atenolol 25 mg, Tablet Levothyroxine sodium 100 mg and Tablet Acetylsalicylic acid 100 mg. Patient had been treated with methylprednisolone and azathioprine. Case 2: A fifty six years old Indian female adult had been treated with Atorvastatin 10 mg, Telmisartan 40 mg and Zolpidem 10 mg for essential hypertension. Patient had been treated with methylprednisolone. Hence there is a need for awareness of the adverse events related to statins therapy to avoid life-threatening complications.
Keywords
Subject
Article metadata
| Title | Atorvastatin Induced Vasculitis |
|---|---|
| Authors | Prasad T; Kalaiselvan V; Surabhi S; Vivek D; Ranvirkumar S; Gyanendra Nath S |
| Affiliations | Scientific Assistant.; Principal Scientific Officer.; Technical Associtae.; Secretary-cum-Scientific Director, National Coordination Centre-Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Sector-23, Raj Nagar Ghaziabad, Uttar Pradesh -201002, India. |
| Corresponding author | prasad.thota187@gmail.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 7, Issue 3 |
Also in this issue
- Editorialpp. 1–1
- Combating Increasing Chronic Non Communicable Diseases: The Need, Progress and Way Forward for Health Promoting Schools in South Africapp. 2–9
- Need for Problem-Based Learning in Clinical Pharmacy Education in Indiapp. 10–13
- Clinical Pharmacist in Nuclear Medicine: A New Role in Ascendancypp. 14–18
- Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of Indiapp. 19–22